FATBB $5.88 -4.6152%
GLOB $136.76 -1.1635%
FXGB.L $1 569.75 0.592759%
POM.PA $15.32 -0.4548%
2215.HK $2.63 -4.0146%
BKTI $13.25 -0.6747%
FOXT.L $39.55 1.4103%
BETZ $17.00 -1.0477%
PSCU $53.71 -0.9309%
BSVN $23.00 0.1306%
BLUE.PA $14.27 0.6594%
0QC9.L $52.68 -2.1834%
GXF $32.28 0%
DPT.PA $0.13 0%
0612.HK $2.23 -5.9072%
FGB $2.90 -0.3436%
PIER.L $58.35 -1.1017%
UAV.L $108.50 2.8436%
RDS-A $51.04 0%
BPOST.BR $4.44 0.0901%
0EE0.L $21.87 -1.4802%
MXUD.L $55.35 0%
AGGG.L $4.41 -0.3951%
IUQD.L $1 495.40 -0.0334%
0327.HK $6.46 -1.374%
0886.HK $0.03 0%
EQNR $27.80 0.1802%
OBAS $12.59 0%
ESDG.L $5 360.50 0.1308%
VCRA $79.13 0%
STNG $48.35 -1.4472%
BSMN $25.12 0%
MLAC $10.51 0%
ENET.L $2.80 -9.0909%
0019.HK $58.25 -1.3548%
1965.HK $2.37 0%
CTG.L $146.60 -2.2667%
HIIIU $10.09 0%
SML.L $0.14 -7.6667%
BURL $172.28 -0.4392%
V3GP.L $4.26 -0.039%
DRR $65.00 0%
SCIN.L $895.00 0%
BANFP $27.05 -0.2897%
ARG.NZ $1.10 0.4566%
IEAC.L $116.10 -0.1634%
AVUS $69.46 -0.7316%
RSKD $4.65 0.2155%
LRFC $20.69 -0.057%
IGLO.L $93.95 -0.3817%
PKB $47.71 -0.9701%
ALNOX.PA $0.04 0%
CYAD $0.58 -6.4878%
COOP $44.44 -0.87%
2263.HK $0.14 6.0606%
FLMI $23.92 -0.2498%
8135.HK $0.24 3.50877%
ASPCW $0.29 0%
BS6.SI $1.18 -3.2787%
1183.HK $1.58 -1.8634%
STARX $14.42 -0.0693%
ODT $1.12 0%
SAFT $70.37 1.2664%
RLIA.MC $1.02 -0.9709%
NERD.CN $0.06 -15.3846%
KINS $1.30 -18.5535%
CHDN $291.54 -0.5831%
GMBTU $9.90 0%
ALR $1.32 0%
SPRE $19.61 0.2469%
GMAT3.SA $6.59 -1.9345%
UKDV.L $10.12 -0.3151%
8078.HK $0.02 0%
0H7R.L $3.09 -4.9231%
SVM $3.45 0.1453%
MS-PF $25.07 -0.0411%
IBEX $18.91 0.0265%
TRV $181.28 -0.8369%
EXPD $112.58 0.1869%
FINM $10.14 0%
UBCB $19.04 0%
FGNA $9.97 0%
6162.HK $0.13 -11.3333%
CENT $36.89 -1.5742%
MODE.L $0.60 0%
83100.HK $35.20 0%
HCII $10.08 0%
DOM.MC $3.67 -0.4071%
AXGN $9.19 0.2181%
VTC.L $1 290.00 0%
NCZ $2.92 -1.1864%
IHYA.L $5.83 -0.3587%
COPX.L $26.94 0.092%
0R2C.L $4.75 -8.1238%
KLCD $29.30 0%
IFIN $10.69 0.0936%
AJG.L $162.00 -0.9174%
6099.HK $7.94 -2.5767%
HEDJ.L $23.04 -0.1301%
ISF.L $763.10 0.2891%
Eng
Логотип
Eng
Лого

ERYTECH Pharma S.A. 0QSS.L

$1.03

+$0.01 (1.12%)
На 18:02, 12 мая 2023

Ключевые показатели

  • Marketcap

    13842923.00000000

  • week52high

    1.29

  • week52low

    0.38

  • Revenue

  • P/E TTM

    0

  • Beta

    2.24923600

  • EPS

    -1.73300000

  • Last Dividend

    0.28500000

  • Next Earnings Date

    07 мая 2023 г. в 04:57

Описание компании

ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-?-lyase in red blood cells to target methionine cancers. The company was incorporated in 2004 and is headquartered in Lyon, France.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек